Bristol Myers Squibb (BMY) Other Working Capital Changes (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Other Working Capital Changes data on file, last reported at $1.6 billion in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $1.6 billion, up 54.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.0 million (up 161.27% YoY), and the FY2025 annual result was -$471.0 million, up 24.52% from the prior year.
• Other Working Capital Changes advanced to $1.6 billion in Q1 2026 per BMY's latest filing, from -$1.1 billion in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.6 billion in Q1 2026 and troughed at -$1.1 billion in Q4 2025.
• A 5-year average of $106.9 million and a median of -$167.0 million in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 185.27% in 2022, then tumbled 383.05% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$700.0 million in 2022, then jumped by 59.57% to -$283.0 million in 2023, then tumbled by 156.18% to -$725.0 million in 2024, then sank by 47.31% to -$1.1 billion in 2025, then jumped by 253.18% to $1.6 billion in 2026.
• Business Quant data shows BMY's Other Working Capital Changes at $1.6 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$240.0 million in Q3 2025.